IL127623A0 - Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses - Google Patents
Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their usesInfo
- Publication number
- IL127623A0 IL127623A0 IL12762397A IL12762397A IL127623A0 IL 127623 A0 IL127623 A0 IL 127623A0 IL 12762397 A IL12762397 A IL 12762397A IL 12762397 A IL12762397 A IL 12762397A IL 127623 A0 IL127623 A0 IL 127623A0
- Authority
- IL
- Israel
- Prior art keywords
- tie
- tie ligand
- provides
- ligand
- growth
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 2
- 102000012753 TIE-2 Receptor Human genes 0.000 title 1
- 108010090091 TIE-2 Receptor Proteins 0.000 title 1
- 102100022007 Tyrosine-protein kinase receptor Tie-1 Human genes 0.000 abstract 8
- 230000012010 growth Effects 0.000 abstract 3
- 102000005450 TIE receptors Human genes 0.000 abstract 2
- 108010006830 TIE receptors Proteins 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 2
- 230000004069 differentiation Effects 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 206010029113 Neovascularisation Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
- C07K14/17—Porcine transmissible gastroenteritis virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/665,926 US5851797A (en) | 1996-06-19 | 1996-06-19 | Tie ligand-3, methods of making and uses thereof |
US2108796P | 1996-07-02 | 1996-07-02 | |
US2299996P | 1996-08-02 | 1996-08-02 | |
PCT/US1997/010728 WO1997048804A2 (en) | 1996-06-19 | 1997-06-19 | Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
IL127623A0 true IL127623A0 (en) | 1999-10-28 |
Family
ID=27361571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12762397A IL127623A0 (en) | 1996-06-19 | 1997-06-19 | Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
Country Status (20)
Country | Link |
---|---|
US (2) | US6432667B1 (xx) |
EP (1) | EP0939809B1 (xx) |
JP (1) | JP2000513932A (xx) |
KR (1) | KR20000022028A (xx) |
CN (1) | CN1227603A (xx) |
AT (1) | ATE235551T1 (xx) |
AU (1) | AU724467B2 (xx) |
CA (1) | CA2258526A1 (xx) |
CZ (1) | CZ421898A3 (xx) |
DE (1) | DE69720241T2 (xx) |
DK (1) | DK0939809T3 (xx) |
ES (1) | ES2194203T3 (xx) |
FI (1) | FI982745A (xx) |
HU (1) | HUP0004320A3 (xx) |
IL (1) | IL127623A0 (xx) |
NO (1) | NO985904L (xx) |
NZ (1) | NZ333374A (xx) |
PL (1) | PL330705A1 (xx) |
PT (1) | PT939809E (xx) |
WO (1) | WO1997048804A2 (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6057435A (en) * | 1997-09-19 | 2000-05-02 | Genentech, Inc. | Tie ligand homologues |
US6350450B1 (en) | 1997-09-19 | 2002-02-26 | Genentech, Inc. | TIE ligand homologue antibody |
US5972338A (en) | 1997-09-19 | 1999-10-26 | Genentech, Inc. | Tie ligands homologues |
US6348350B1 (en) | 1997-09-19 | 2002-02-19 | Genentech, Inc. | Ligand homologues |
US6030831A (en) * | 1997-09-19 | 2000-02-29 | Genetech, Inc. | Tie ligand homologues |
WO1999067382A2 (en) * | 1998-06-24 | 1999-12-29 | Compugen Ltd. | Angiopoietin-like growth factor sequences |
SI1135153T1 (xx) * | 1998-11-20 | 2005-08-31 | Genentech Inc | |
ES2242437T3 (es) * | 1998-11-20 | 2005-11-01 | Genentech, Inc. | Utilizaciones de agonistas y antagonistas del receptor eph para el tratamiento de trastornos vasculares. |
EP1141294B1 (en) | 1998-12-23 | 2005-03-02 | Regeneron Pharmaceuticals, Inc. | Method of enhancing the biological activity of ligands |
AU2002335085A1 (en) | 2001-10-25 | 2003-05-06 | Regeneron Pharmaceuticals, Inc. | Angiopoietins and methods of use thereof |
US8298532B2 (en) | 2004-01-16 | 2012-10-30 | Regeneron Pharmaceuticals, Inc. | Fusion polypeptides capable of activating receptors |
US7296991B2 (en) * | 2004-12-10 | 2007-11-20 | Irwin Jere F | Adjustable extruder die assembly die lip adjustment apparatus |
US20080119367A1 (en) * | 2004-12-17 | 2008-05-22 | Mayo Foundation For Medical Education And Research | Prognosis of Renal Cell Carcinoma |
WO2007030658A2 (en) * | 2005-09-08 | 2007-03-15 | Children's Hospital Medical Center | Compositions useful for and methods of modulating angiogenesis |
US20080080059A1 (en) * | 2006-09-28 | 2008-04-03 | Pacific Biosciences Of California, Inc. | Modular optical components and systems incorporating same |
EP3359158A4 (en) | 2015-09-29 | 2019-05-08 | Prodrugxtend PTY Ltd | FORMULATIONS AND METHODS OF TREATMENT NEWS |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5332671A (en) | 1989-05-12 | 1994-07-26 | Genetech, Inc. | Production of vascular endothelial cell growth factor and DNA encoding same |
AU4651893A (en) * | 1992-06-26 | 1994-01-24 | Immunex Corporation | Novel tyrosine kinase |
CN1701814A (zh) | 1992-11-13 | 2005-11-30 | 马克斯普朗克科学促进协会 | 作为血管内皮生长因子受体的f1k-1 |
US5643755A (en) * | 1994-10-07 | 1997-07-01 | Regeneron Pharmaceuticals Inc. | Nucleic acid encoding tie-2 ligand |
US5814464A (en) * | 1994-10-07 | 1998-09-29 | Regeneron Pharma | Nucleic acids encoding TIE-2 ligand-2 |
EP0854185A3 (en) * | 1994-12-23 | 1998-10-21 | Ludwig Institute For Cancer Research | Assay receptor proteins and ligands |
AU715621B2 (en) * | 1995-04-06 | 2000-02-03 | Regeneron Pharmaceuticals, Inc. | TIE-2 ligands, methods of making and uses thereof |
US5851797A (en) * | 1996-06-19 | 1998-12-22 | Regeneron Pharmaceuticals, Inc. | Tie ligand-3, methods of making and uses thereof |
-
1997
- 1997-06-19 AU AU34061/97A patent/AU724467B2/en not_active Ceased
- 1997-06-19 US US09/202,491 patent/US6432667B1/en not_active Expired - Lifetime
- 1997-06-19 CN CN97197208A patent/CN1227603A/zh active Pending
- 1997-06-19 EP EP97930162A patent/EP0939809B1/en not_active Expired - Lifetime
- 1997-06-19 CZ CZ984218A patent/CZ421898A3/cs unknown
- 1997-06-19 PL PL97330705A patent/PL330705A1/xx unknown
- 1997-06-19 PT PT97930162T patent/PT939809E/pt unknown
- 1997-06-19 AT AT97930162T patent/ATE235551T1/de not_active IP Right Cessation
- 1997-06-19 DK DK97930162T patent/DK0939809T3/da active
- 1997-06-19 IL IL12762397A patent/IL127623A0/xx unknown
- 1997-06-19 NZ NZ333374A patent/NZ333374A/en unknown
- 1997-06-19 WO PCT/US1997/010728 patent/WO1997048804A2/en not_active Application Discontinuation
- 1997-06-19 JP JP10503376A patent/JP2000513932A/ja not_active Withdrawn
- 1997-06-19 ES ES97930162T patent/ES2194203T3/es not_active Expired - Lifetime
- 1997-06-19 HU HU0004320A patent/HUP0004320A3/hu unknown
- 1997-06-19 CA CA002258526A patent/CA2258526A1/en not_active Abandoned
- 1997-06-19 DE DE69720241T patent/DE69720241T2/de not_active Expired - Fee Related
- 1997-06-19 KR KR1019980710426A patent/KR20000022028A/ko not_active Application Discontinuation
-
1998
- 1998-12-16 NO NO985904A patent/NO985904L/no not_active Application Discontinuation
- 1998-12-18 FI FI982745A patent/FI982745A/fi unknown
-
2002
- 2002-08-08 US US10/214,812 patent/US6881395B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
HUP0004320A2 (hu) | 2001-06-28 |
WO1997048804A2 (en) | 1997-12-24 |
EP0939809A2 (en) | 1999-09-08 |
NO985904L (no) | 1999-02-19 |
NZ333374A (en) | 2000-06-23 |
DK0939809T3 (da) | 2003-07-21 |
PL330705A1 (en) | 1999-05-24 |
US20030064470A1 (en) | 2003-04-03 |
DE69720241D1 (de) | 2003-04-30 |
NO985904D0 (no) | 1998-12-16 |
ES2194203T3 (es) | 2003-11-16 |
FI982745A0 (fi) | 1998-12-18 |
KR20000022028A (ko) | 2000-04-25 |
EP0939809B1 (en) | 2003-03-26 |
ATE235551T1 (de) | 2003-04-15 |
JP2000513932A (ja) | 2000-10-24 |
CA2258526A1 (en) | 1997-12-24 |
WO1997048804A3 (en) | 1998-04-09 |
DE69720241T2 (de) | 2003-12-11 |
PT939809E (pt) | 2003-08-29 |
US6432667B1 (en) | 2002-08-13 |
HUP0004320A3 (en) | 2005-11-28 |
AU724467B2 (en) | 2000-09-21 |
CN1227603A (zh) | 1999-09-01 |
FI982745A (fi) | 1999-02-04 |
AU3406197A (en) | 1998-01-07 |
US6881395B2 (en) | 2005-04-19 |
CZ421898A3 (cs) | 1999-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL154113A0 (en) | Tie-2 ligands, methods for their preparation and uses thereof | |
HK1008230A1 (en) | Tie-2 ligands, methods of making and uses thereof. | |
IL127623A0 (en) | Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses | |
WO1994022478A1 (en) | PREVENTION OF TUMORS WITH MONOCLONAL ANTIBODIES AGAINST $i(NEU) | |
MY145191A (en) | Human antibodies that bind human il-12 and methods for producing | |
MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
GB8925590D0 (en) | Monoclonal antibodies | |
WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
AU2001235761A1 (en) | Diagnosis of breast cancer using bcmp-11 as marker | |
WO2001064876A3 (en) | Human schizophrenia gene | |
WO2002100343A3 (en) | N-terminally truncated galectin-3 and antibodies for treating cancer | |
ATE298244T1 (de) | Monoklonaler antikörper mit selektiver bindung an vgf und verwendung zur behandlung von vgf- erkrankungen | |
AU2347501A (en) | Trp-protein-related mtr1 protein and dna sequence coding therefor | |
AU5873298A (en) | Cathepsin k and breast cancer |